US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

593.41

-26.4041-4.26%

Number of Gainers:18

Number of Losers:140

Number of Flat:9

PE:- -

High:619.76

Open:619.76

Low:592.62

Close:619.81

Volume:312.05M

Turnover:8.72B

Market Cap:445.81B

Float Cap:320.26B

Loading ...

PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant

SentinelOne files initial beneficial ownership statement; CFO Sonalee Elizabeth Parekh reports no securities beneficially owned

Centessa Pharmaceuticals; Chief Business Officer Gregory M Weinhoff disposes of 23,998 common shares valued at $719,940

Rain City Resources Targets March 30 to Clear Filing Default and Cease Trade Order

Good Morning Sichuan: A Glimpse into Smart Spring

AtaiBeckley initiated with a Buy at Deutsche Bank

PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress

Morning Insights by Zhang Xiaojie

VTEX files initial beneficial ownership statement; CFO Ricardo Sodre reports 471,124 Class A common shares

Trump to sign executive order paying TSA amid DHS shutdown, Bloomberg says

Corrected-Century Therapeutics Inc - Sold $18.4 Mln in Common Stock Through TD Cowen - SEC Filing (Not 'May Offer $150 Mln')

THOMSON REUTERS

Rani Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Inspira Technologies Oxy FY EPS $(0.45) Misses $(0.44) Estimate, Sales $289.000K Miss $19.493M Estimate

Dermata Therapeutics FY2025 net loss narrows 38.5% to $7.6 million; cash and cash equivalents climb 138% to $8 million

Paymentus General Counsel Andrew Gerber Announces Upcoming Departure

Century Therapeutics Updates ATM Program to Enhance Liquidity

Inspira Technologies Ends Bio-View Deal, Strengthens Nasdaq Compliance as 2025 Loss Narrows Growth Path

EpicQuest Education Group International filed Form 3; Director Gary Michael Pratt reports 1,775 ordinary shares beneficially owned

Century Therapeutics updates $150.0 million ATM program; $131.6 million remains available for sale

Century Therapeutics Inc - May Offer up to $150 Mln in Common Stock Through TD Cowen - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4539/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":593.40814,"timestamp":1774641599999,"preClose":619.8122,"halted":0,"volume":312051776,"delay":0,"changeRate":-0.0426,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-26.404053,"latestTime":"03-27 16:00:00 EDT","open":619.76276,"high":619.76447,"low":592.62305,"amount":8716790920.053452,"amplitude":0.04379,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.090165,"peRate":168.263558,"turnoverRate":0.022172,"increases":18,"decrements":140,"flats":4,"marketCap":445810669823.375,"floatMarketCap":320261614730.4375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":619.76447,"amplitude":0.04379,"preClose":619.8122,"low":592.62305,"pbRate":"5.090165","latestPrice":593.40814,"volume":312051776,"delay":0,"open":619.76276,"prevYearClose":881.5255,"prevWeekClose":652.8748,"prevMonthClose":663.4647,"prevQuarterClose":881.5255,"fiveDayClose":652.8748,"twentyDayClose":663.4647,"sixtyDayClose":897.8409,"secType":"PLATE","market":"US","turnoverRate":0.022172,"peRate":168.263558,"marketCap":445810669823.375,"floatMarketCap":320261614730.4375,"timestamp":1774641599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":18,"down":140,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622160128","title":"PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2622160128","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622160128?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:27","pubTimestamp":1774578455,"startTime":"0","endTime":"0","summary":"The latest announcement is out from PYC Therapeutics Limited ( ($AU:PYC) ). PYC Therapeutics has disclosed a change in the holdings of director Dr ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-ceo-increases-shareholding-and-receives-major-option-grant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-ceo-increases-shareholding-and-receives-major-option-grant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2622815453","title":"SentinelOne files initial beneficial ownership statement; CFO Sonalee Elizabeth Parekh reports no securities beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622815453","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622815453?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:52","pubTimestamp":1774576320,"startTime":"0","endTime":"0","summary":"SentinelOne files initial beneficial ownership statement; CFO Sonalee Elizabeth Parekh reports no securities beneficially owned. SentinelOne filed a Form 3 initial statement of beneficial ownership for Sonalee Elizabeth Parekh in her role as chief financial officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SentinelOne Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL5LFfR7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4560","LU2286300806.USD","BK4585","BK4097","BK4561","S","BK4588","BK4539"],"gpt_icon":0},{"id":"2622186688","title":"Centessa Pharmaceuticals; Chief Business Officer Gregory M Weinhoff disposes of 23,998 common shares valued at $719,940","url":"https://stock-news.laohu8.com/highlight/detail?id=2622186688","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622186688?lang=en_us&edition=fundamental","pubTime":"2026-03-27 08:36","pubTimestamp":1774571819,"startTime":"0","endTime":"0","summary":"Centessa reported that Chief Business Officer Gregory Weinhoff acquired 23,998 ordinary shares on March 26, 2026 at USD 3.85 per share.The filing also reported Gregory Weinhoff sold 23,998 ordinary shares on March 26, 2026 at USD 30 per share.Following the reported transactions, Gregory Weinhoff held 65,925 ordinary shares.The filing reported the exercise of 23,998 share options at an exercise price of USD 3.85.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the infor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLbKv38Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Centessa Pharmaceuticals; Chief Business Officer Gregory M Weinhoff disposes of 23,998 common shares valued at $719,940","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","BK4535","BK4539","BK4139"],"gpt_icon":0},{"id":"2622205890","title":"Rain City Resources Targets March 30 to Clear Filing Default and Cease Trade Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2622205890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622205890?lang=en_us&edition=fundamental","pubTime":"2026-03-27 08:02","pubTimestamp":1774569746,"startTime":"0","endTime":"0","summary":"Rain City Resources ( ($TSE:RAIN) ) has provided an announcement. Rain City Resources issued an update on the management cease trade order imposed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rain-city-resources-targets-march-30-to-clear-filing-default-and-cease-trade-order?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rain-city-resources-targets-march-30-to-clear-filing-default-and-cease-trade-order?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RAIN","BK4161","CHCO","BK4007","BK4211"],"gpt_icon":0},{"id":"1150435692","title":"Good Morning Sichuan: A Glimpse into Smart Spring","url":"https://stock-news.laohu8.com/highlight/detail?id=1150435692","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150435692?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:51","pubTimestamp":1774569117,"startTime":"0","endTime":"0","summary":"Image source: Visual China Group Co.,Ltd.\nFor extensive financial news and insightful analysis, visit the SINA Corp Finance App.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1861215975.USD","LU2250418816.HKD","SINA","LU2360106780.USD","LU1852331112.SGD","BK4023","LU2290526834.HKD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","BK4608","LU2063271972.USD","IE00B19Z9P08.USD","IE00B894F039.SGD","APPX","LU0353189680.USD","BK4613","000681","BK4539","LU2087625088.SGD","LU1861220033.SGD","BK4585","LU0056508442.USD","LU2360107168.USD","LU0097036916.USD","LU0353189763.USD"],"gpt_icon":0},{"id":"2622288897","title":"AtaiBeckley initiated with a Buy at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2622288897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622288897?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:25","pubTimestamp":1774567513,"startTime":"0","endTime":"0","summary":"Deutsche Bank initiated coverage of AtaiBeckley (ATAI) with a Buy rating and $12 price target Published first on TheFly – the ultimate source for r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ataibeckley-initiated-with-a-buy-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ataibeckley-initiated-with-a-buy-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATAI","BK4588","BK4007","BK4118","DB","BK4552","BK4539","BK4566","BK4585"],"gpt_icon":0},{"id":"2622889754","title":"PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2622889754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622889754?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:19","pubTimestamp":1774567153,"startTime":"0","endTime":"0","summary":"The latest announcement is out from PYC Therapeutics Limited ( ($AU:PYC) ). PYC Therapeutics is advancing its PYC-003 drug candidate, designed to a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-to-showcase-pkd-drug-progress-at-world-nephrology-congress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-to-showcase-pkd-drug-progress-at-world-nephrology-congress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4097","BK4007","LU2065732104.USD","BK4139","BK4539","PKD","PRGS"],"gpt_icon":0},{"id":"1198563818","title":"Morning Insights by Zhang Xiaojie","url":"https://stock-news.laohu8.com/highlight/detail?id=1198563818","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198563818?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:11","pubTimestamp":1774566670,"startTime":"0","endTime":"0","summary":"Zhang Xiaojie presents Morning Insights, delivering a wealth of information and precise analysis exclusively available through the SINA Corp financial application.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0056508442.USD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","BK4585","LU0353189680.USD","LU2360106780.USD","LU1852331112.SGD","LU2250418816.HKD","LU1861220033.SGD","LU0097036916.USD","APPX","LU2087625088.SGD","SINA","BK4023","BK4588","LU0353189763.USD","LU2290526834.HKD","BK4539","BK4608","BK4613","IE00B19Z9Z06.USD","LU2360107168.USD","LU1861215975.USD","LU2063271972.USD","APP","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2622289299","title":"VTEX files initial beneficial ownership statement; CFO Ricardo Sodre reports 471,124 Class A common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622289299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622289299?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:45","pubTimestamp":1774565150,"startTime":"0","endTime":"0","summary":"VTEX Chief Financial Officer Ricardo Sodre filed an initial statement of beneficial ownership reporting 471,124 Class A common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VTEX published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL6qbNnV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4116","BK4549","VTEX","BK4077"],"gpt_icon":0},{"id":"2622892630","title":"Trump to sign executive order paying TSA amid DHS shutdown, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2622892630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622892630?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:40","pubTimestamp":1774564843,"startTime":"0","endTime":"0","summary":"Publicly traded companies in the airline space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), Frontier Group (ULCC), Jet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trump-to-sign-executive-order-paying-tsa-amid-dhs-shutdown-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trump-to-sign-executive-order-paying-tsa-amid-dhs-shutdown-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DAL","IE00BFMHRM44.USD","BK4585","ULCC","BK4008","BK4588","ARKX","LU0128525689.USD","BK4544","DHS","BK4547","LU1267930227.SGD","AAL","LU0310800965.SGD","AALG","LU0052756011.USD","UFO","BK4564","ALK","BK4500","BK4539"],"gpt_icon":0},{"id":"2622894115","title":"Corrected-Century Therapeutics Inc - Sold $18.4 Mln in Common Stock Through TD Cowen - SEC Filing (Not 'May Offer $150 Mln')","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622894115?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:00","pubTimestamp":1774562450,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL8N40E2LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IPSC","BK4539","BK4505"],"gpt_icon":0},{"id":"2622894336","title":"Rani Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894336","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622894336?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:38","pubTimestamp":1774561121,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings SummaryRani Therapeutics Holdings Inc RANI.OQ reported a quarterly adjusted loss of 12 cents per share for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL8N40E2KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","BK4539","BK4007"],"gpt_icon":0},{"id":"2622289486","title":"Inspira Technologies Oxy FY EPS $(0.45) Misses $(0.44) Estimate, Sales $289.000K Miss $19.493M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2622289486","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622289486?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:32","pubTimestamp":1774560762,"startTime":"0","endTime":"0","summary":"Inspira Technologies Oxy (NASDAQ:IINN) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.44) by 2.27 percent. This is a 25 percent increase over losses of $(0.60) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51498114/inspira-technologies-oxy-fy-eps-0-45-misses-0-44-estimate-sales-289-000k-miss-19-493m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Inspira Technologies Oxy FY EPS $(0.45) Misses $(0.44) Estimate, Sales $289.000K Miss $19.493M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IINN","BK4539"],"gpt_icon":0},{"id":"2622891491","title":"Dermata Therapeutics FY2025 net loss narrows 38.5% to $7.6 million; cash and cash equivalents climb 138% to $8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622891491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622891491?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:17","pubTimestamp":1774559838,"startTime":"0","endTime":"0","summary":"Dermata filed a Form 8-K reporting full-year 2025 results, including a net loss of USD 7.6 million.Research and development expense fell 64.27% to USD 2.9 million, primarily due to lower clinical costs after completion of the STAR-1 acne study in Q2 2025.Selling, general and administrative expense rose 12.42% to USD 4.8 million, driven mainly by USD 0.7 million in marketing expense.Cash and cash equivalents were USD 7.5 million as of Dec. 31, 2025, and the company said its cash resources are expected to fund operations into Q1 2027.Management said Dermata is pivoting to direct-to-consumer skincare under the Tome brand, with a first product launch targeted for mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL2J3K1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4007","DRMA"],"gpt_icon":0},{"id":"2622917318","title":"Paymentus General Counsel Andrew Gerber Announces Upcoming Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2622917318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622917318?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:07","pubTimestamp":1774559262,"startTime":"0","endTime":"0","summary":"Paymentus Holdings ( ($PAY) ) has issued an update. Paymentus Holdings, Inc. announced that its General Counsel and Corporate Secretary, Andrew Ger...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/paymentus-general-counsel-andrew-gerber-announces-upcoming-departure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/paymentus-general-counsel-andrew-gerber-announces-upcoming-departure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4106","PAY","BK4227"],"gpt_icon":0},{"id":"2622787891","title":"Century Therapeutics Updates ATM Program to Enhance Liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=2622787891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622787891?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:04","pubTimestamp":1774559075,"startTime":"0","endTime":"0","summary":"Century Therapeutics ( ($IPSC) ) has shared an announcement. On July 10, 2025, Century Therapeutics, Inc. filed a new shelf registration statement ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-updates-atm-program-to-enhance-liquidity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-updates-atm-program-to-enhance-liquidity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPSC","BK4505","BK4139","BK4539"],"gpt_icon":0},{"id":"2622089122","title":"Inspira Technologies Ends Bio-View Deal, Strengthens Nasdaq Compliance as 2025 Loss Narrows Growth Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089122?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:03","pubTimestamp":1774559032,"startTime":"0","endTime":"0","summary":"Inspira Technologies Oxy BHN ( ($IINN) ) has issued an update. Inspira Technologies reported full-year 2025 results on March 26, 2026, highlighting...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inspira-technologies-ends-bio-view-deal-strengthens-nasdaq-compliance-as-2025-loss-narrows-growth-path?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inspira-technologies-ends-bio-view-deal-strengthens-nasdaq-compliance-as-2025-loss-narrows-growth-path?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4539","BK4082","IINN"],"gpt_icon":0},{"id":"2622891581","title":"EpicQuest Education Group International filed Form 3; Director Gary Michael Pratt reports 1,775 ordinary shares beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622891581","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622891581?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:01","pubTimestamp":1774558913,"startTime":"0","endTime":"0","summary":"EpicQuest Education Group International filed Form 3; Director Gary Michael Pratt reports 1,775 ordinary shares beneficially owned. EpicQuest said director Gary Michael Pratt filed an initial Form 3 reporting 1,775 ordinary shares held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EpicQuest Education Group International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLS2TP2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EEIQ","BK4539","BK4204"],"gpt_icon":0},{"id":"2622899213","title":"Century Therapeutics updates $150.0 million ATM program; $131.6 million remains available for sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899213","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899213?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:43","pubTimestamp":1774557793,"startTime":"0","endTime":"0","summary":"Century Therapeutics filed a new prospectus supplement for its at-the-market equity offering program for up to USD 150.0 million in common stock sales.TD Securities  is acting as sales agent under a sales agreement dated July 1, 2022.Common stock sold under the program totaled USD 18.38 million, leaving USD 131.62 million available for future sales.The company said its new shelf registration statement on Form S-3 became effective on January 9, 2026, replacing its prior shelf registration statement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Century Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL1W0SSN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","IPSC","BK4139","BK4539"],"gpt_icon":0},{"id":"2622989923","title":"Century Therapeutics Inc - May Offer up to $150 Mln in Common Stock Through TD Cowen - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622989923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622989923?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:42","pubTimestamp":1774557765,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4505","IPSC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":75,"pageCount":7,"totalSize":1494,"code":"91000000","status":"200"}]}}